Biochemistry and Cell Biology
Scope & Guideline
Innovating research for a deeper understanding of life at the molecular level.
Introduction
Aims and Scopes
- Molecular Mechanisms in Disease:
The journal extensively covers studies exploring the molecular pathways involved in various diseases, particularly cancer, autoimmune disorders, and metabolic syndromes. - Biochemical Interactions and Signaling Pathways:
Research articles delve into the signaling pathways and biochemical interactions that regulate cellular functions, emphasizing the roles of proteins, lipids, and nucleic acids. - Innovative Therapeutic Strategies:
A strong emphasis is placed on the development of novel therapeutic approaches, including drug design, genetic engineering, and the application of nanotechnology in medicine. - Cellular and Molecular Biology:
The journal provides insights into cellular processes such as apoptosis, autophagy, and cell signaling, linking basic biology to health and disease. - Biotechnology and Bioengineering:
Research on the application of biochemical principles in biotechnology, including genetic modifications, biopharmaceuticals, and environmental applications, is featured prominently.
Trending and Emerging
- Cancer Immunotherapy:
A significant increase in research focusing on the mechanisms and therapeutic potentials of immunotherapy in cancer treatment has emerged, reflecting the growing interest in harnessing the immune system for cancer therapy. - MicroRNA and Non-Coding RNAs:
Studies exploring the roles of microRNAs and long non-coding RNAs in gene regulation and disease mechanisms are trending, indicating a shift towards understanding epigenetic and post-transcriptional control. - Ferroptosis and Cell Death Mechanisms:
Research on ferroptosis, a form of regulated cell death distinct from apoptosis, is gaining traction as scientists explore its implications in cancer and neurodegenerative diseases. - Advanced Genomic Techniques:
The integration of CRISPR/Cas9 and other gene-editing technologies into biochemical research is increasingly prevalent, indicating a trend towards precision medicine and targeted therapies. - Multi-Omics Approaches:
There is a rising interest in multi-omics studies that combine genomics, proteomics, and metabolomics to provide comprehensive insights into biological systems and disease states.
Declining or Waning
- Traditional Pharmacological Approaches:
Research centered on conventional pharmacology, particularly studies that do not integrate modern biotechnological advancements, has decreased, indicating a shift toward more innovative therapeutic strategies. - Basic Plant Biochemistry:
There has been a notable decline in studies focusing solely on plant biochemistry without direct applications or implications in human health or disease. - Animal Models in Biochemical Research:
The use of traditional animal models in biochemical studies is less frequent, as there is a growing preference for more sophisticated in vitro models or human-derived systems that better mimic disease conditions.
Similar Journals
BIOCHIMIE
Advancing the Frontiers of Biochemistry and MedicineWelcome to BIOCHIMIE, a prestigious journal dedicated to advancing the field of biochemistry and related areas of medicine. Published by Elsevier France - Editions Scientifiques Medicales Elsevier, this journal has been a cornerstone of scientific communication since its inception in 1971 and will continue to contribute essential research until 2024. With an impressive impact factor and categorized in Q2 for Biochemistry and Q1 for Miscellaneous Medicine, BIOCHIMIE ranks among the top quartiles in its fields, underscoring its significance and influence in the scientific community. Targeting a wide audience of researchers, professionals, and students, the journal publishes high-quality articles that explore innovative research and developments in biochemistry, genetics, and molecular biology, reflected in its Scopus ranking of 136 out of 438 in the biochemistry category. Despite its traditional publication format, the journal remains committed to promoting impactful research that drives the future of biochemistry and molecular medicine, ensuring that readers have access to critical insights that foster advancements in health and science.
Biochemistry Moscow Supplement Series A-Membrane and Cell Biology
Exploring the Frontiers of Membrane DynamicsBiochemistry Moscow Supplement Series A-Membrane and Cell Biology, published by PLEIADES PUBLISHING INC in the United States, is a pivotal journal in the fields of biochemistry, biophysics, and cell biology. Established in 2008, this journal has become a significant platform for disseminating novel research findings and reviews, fostering advanced studies in membrane dynamics and cellular processes. Although currently ranked in the Q4 quartile across its categories, the journal provides researchers and professionals with open access to a wealth of knowledge, helping to bridge gaps in understanding complex biochemical mechanisms. The journal’s commitment to quality and relevance is evident as it continues to contribute to the academic community through its coverage of innovative and emerging topics in cell and membrane biology. Researchers, practitioners, and students alike will find this resource invaluable for keeping abreast of the latest developments in the ever-evolving landscape of biochemistry and cellular research.
BIOCHEMISTRY-MOSCOW
Exploring the Intersection of Science and HealthBIOCHEMISTRY-MOSCOW is a distinguished academic journal published by MAIK NAUKA/INTERPERIODICA/SPRINGER, focusing on pivotal research in the fields of biochemistry, biophysics, geriatrics, and broader medical sciences. Established in 1972, the journal has a rich history of disseminating critical findings and innovative studies, making significant contributions to the advancement of biochemical knowledge and applications. With its Q2 ranking in various categories including biochemistry and gerontology, the journal commands respect within the scientific community, offering a reputable platform for both established researchers and emerging scholars alike. Although traditionally not an open-access journal, it provides a wealth of information accessible through institutional subscriptions, ensuring the latest advancements reach a global audience. The journal aims to enhance understanding of biochemical processes and their implications for human health, and its commitment to high-quality peer-reviewed content has established it as a vital resource for those invested in the life sciences.
CELLULAR & MOLECULAR BIOLOGY LETTERS
Unlocking the Secrets of Life at the Molecular LevelCELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.
Cell Death & Disease
Exploring the frontiers of cell biology and therapeutic innovation.Cell Death & Disease, published by SpringerNature, is a premier open-access journal dedicated to disseminating high-quality research on the mechanisms and implications of cell death, disease pathology, and therapeutic responses. Since its inception in 2010, the journal has quickly established itself within the top tier of academic publishing, achieving a notable impact factor and earning Q1 rankings in several critical categories including Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, Immunology, and Medicine (miscellaneous). With its commitment to open access, Cell Death & Disease ensures that groundbreaking research is available to a global audience, fostering collaboration and advancing knowledge across disciplines. Residing at the forefront of crucial scientific discourse, this journal not only attracts submissions from leading researchers but also significantly influences the fields of molecular biology, immunology, and neurology. By bridging the gap between basic science and clinical applications, it provides vital insights for professionals, academicians, and students alike.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
Exploring Complex Biological Processes with PrecisionBIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, published by Elsevier, serves as a pivotal journal in the fields of biochemistry and biophysics, with a long-standing history dating back to 1956. This esteemed publication, bearing the ISSN 0304-4165 and E-ISSN 1872-8006, continuously contributes to advancing our understanding of complex biological processes through rigorous research articles and reviews. It notably holds a distinguished position with a Q2 classification in Biochemistry and a Q1 ranking in Biophysics for 2023, reflecting its high relevance and impact within these scientific domains. The journal is also recognized within the Scopus metrics, taking a rank of #40 out of 152 in Biophysics and #173 out of 438 in Biochemistry, thus placing it in the 74th and 60th percentiles respectively. Academics and professionals in the life sciences will find this journal an essential resource for current research, cutting-edge techniques, and comprehensive reviews aimed at enhancing the understanding of biological functions. While BIOCHIMICA ET BIOPHYSICA ACTA is not an open-access journal, it remains a cornerstone publication for those seeking to stay at the forefront of biochemical and biophysical research.
BIOCHEMICAL JOURNAL
Advancing the Frontiers of Biochemical ResearchBIOCHEMICAL JOURNAL, published by Portland Press Ltd, stands as a leading publication in the fields of Biochemistry, Cell Biology, and Molecular Biology, reflecting a commitment to advancing scientific knowledge since its inception in 1945. With a distinguished Q1 ranking across these categories and impressive Scopus rankings, the journal serves as an invaluable resource for researchers, professionals, and students alike, facilitating critical discoveries and innovative research practices. Although not currently offering open access, the journal provides a platform for high-quality peer-reviewed articles, ensuring rigorous standards in the dissemination of biochemical research. Spanning over seven decades and continuing through to 2024, the BIOCHEMICAL JOURNAL fosters an environment where cutting-edge biochemical research thrives, supporting the global scientific community's efforts to address complex biological questions and enhance our understanding of fundamental cellular processes.
BIOCELL
Advancing the Frontiers of Cell BiologyBIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.
MOLECULAR AND CELLULAR BIOCHEMISTRY
Elevating Knowledge in Biochemistry Since 1973MOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.
CELLULAR AND MOLECULAR BIOLOGY
Fostering Novel Insights in Molecular ResearchCellular and Molecular Biology is a prominent academic journal published by C M B ASSOC, specializing in the dynamic fields of cellular and molecular biology. Established in 1977, this journal has consistently aimed to disseminate groundbreaking research that contributes to our understanding of biochemical processes, cell dynamics, and molecular mechanisms governing life. With its ISSN 0145-5680 and E-ISSN 1165-158X, the journal plays a vital role in the exchange of innovative ideas, evidenced by its coverage of research from 1977 to 2024. Although currently categorized in the Q4 quartile for major disciplines such as Biochemistry and Cell Biology, it is dedicated to fostering the development of the field by welcoming submissions that challenge the conventional understanding and lead to novel insights. Researchers and academics looking to contribute to or stay updated in the rapidly evolving landscape of molecular biology will find this journal a valuable resource for connecting with a global community of scientists.